Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Pet Health News Calls Of The Day Elanco Animal Health Ceo, Casey S General Store, Ge Vernova, Spotify

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Pet Health News Calls Of The Day Elanco Animal Health Ceo, Casey S General Store, Ge Vernova, Spotify is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Pet Health News Calls Of The Day Elanco Animal Health Ceo, Casey S General Store, Ge Vernova, Spotify | RobinsPost News & Noticias

Elanco’s Q3 2025 Earnings Call Highlights Strong Growth


Elanco Animal Health ((ELAN)) has held its Q3 earnings call. Read on for the main highlights of the call. Elanco Animal Health’s recent earnings call highlighted a positive sentiment, driven by strong ... Read More

Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space


Shares of Elanco Animal Health (ELAN) and Zoetis (ZTS) traded higher on Friday after KeyBanc Capital Markets initiated the rival veterinary product makers with Overweight and Sector Weight ratings, ... Read More

Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript


Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I will now hand the call over to Tiffany Kanaga, ... Read More

Elanco Animal Health Stock Is Undervalued: Analyst


KeyBanc initiates Elanco with an Overweight rating, citing strong Innovation Product growth, margin gains, and a path to lower leverage. Read More

Elanco Animal Health Reports Third Quarter 2025 Results


Revenue of $1,137 million, an increase of 10% year-over-year; 9% organic constant currency growth Reported Net Loss of $34 million, Adjusted Net Income of $94 million Adjusted EBITDA of $198 million; ... Read More

Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats


The U.S. Food and Drug Administration on Friday authorized emergency use of Elanco Animal Health's chewable tablet to treat the infestation of a parasite in cats known as New World screwworm. Read More

Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms


Oct 24 (Reuters) - Elanco Animal Health (ELAN.N), opens new tab said on Friday it had received an emergency use authorization from the U.S. Food and Drug Administration for its flea and tick drug to ... Read More

Elanco Animal Health Reports Third Quarter 2025 Results


(1) Organic CC Growth = Represents revenue growth excluding the impacts from our prior year divestiture of the aqua business, which was divested July 9, 2024, royalty revenue that was sold to a third ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus